聚合酵素链锁反应(PCR) 市场规模、份额及成长分析（按类型、产品、适应症、最终用户和地区）－2025 年至 2032 年产业预测

聚合酵素链锁反应(PCR) 市场规模预计在 2023 年达到 101 亿美元，并从 2024 年的 109.5 亿美元增长到 2032 年的 208.7 亿美元，预测期内（2025-2032 年）的复合年增长率为 8.4%。

近年来，全球聚合酵素链锁反应(PCR) 市场经历了显着成长，因为它已成为分子生物学和诊断领域的关键技术。这种多功能方法对于 DNA 和 RNA 样本的扩增和分析至关重要，可应用于研究、临床诊断、法医学和生物技术。市场扩张的主要驱动因素包括感染疾病率上升、个人化医疗的需求、基因组学的进步以及对快速准确诊断的需求，尤其是在 COVID-19 大流行之后。市场上有许多领先的公司提供各种 PCR 工具、耗材和服务。传统技术正在转向更有效率、自动化的解决方案，如即时PCR和数位 PCR，从而提供更高的速度和灵敏度。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管格局
• 案例研究
• 技术进步

聚合酵素链锁反应（PCR）市场规模（按类型及复合年增长率）（2025-2032）

• 市场概览
• 标准PCR
• 即时PCR
• 数位PCR

聚合酵素链锁反应（PCR）市场规模（依产品及复合年增长率）（2025-2032）

• 市场概览
• 装置
• 试剂和耗材

聚合酵素链锁反应（PCR）市场规模（按适应症和复合年增长率）（2025-2032）

• 市场概览
• 感染疾病
• 肿瘤学
• 遗传性疾病
• 其他的

聚合酵素链锁反应（PCR）市场规模（依最终用户划分）及复合年增长率（2025-2032）

• 市场概览
• 医院和诊所
• 製药和生物技术产业
• 诊断中心
• 学术和研究机构

聚合酵素链锁反应（PCR）市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Abbott Laboratories（USA）
• Agilent Technologies（USA）
• Thermo Fisher Scientific（USA）
• Siemens Healthineers（Germany）
• bioMerieux（France）
• Becton, Dickinson and Company（USA）
• Bio-Rad Laboratories（USA）
• Merck KGaA（Germany）
• PerkinElmer（USA）
• Promega Corporation（USA）
• Danaher Corporation（USA）
• QIAGEN（Netherlands）
• QuantuMDx Group Ltd（UK）
• Eppendorf（Germany）
• Fluidigm Corporation（USA）
• Microsynth AG（Switzerland）
• JN Medsys（Singapore）
• Takara Bio Inc（Japan）

结论和建议

Polymerase Chain Reaction (PCR) Market size was valued at USD 10.1 billion in 2023 and is poised to grow from USD 10.95 billion in 2024 to USD 20.87 billion by 2032, growing at a CAGR of 8.4% during the forecast period (2025-2032).

The global polymerase chain reaction (PCR) market has seen remarkable growth recently, emerging as a crucial technology in molecular biology and diagnostics. This versatile method, essential for amplifying and analyzing DNA and RNA samples, finds applications across research, clinical diagnostics, forensics, and biotechnology. Key drivers of market expansion include rising rates of infectious diseases, the demand for personalized medicine, advancements in genomics, and the necessity for rapid, accurate diagnostics, particularly in the aftermath of the COVID-19 pandemic. The market boasts numerous leading players offering a diverse array of PCR tools, consumables, and services. Traditional techniques are shifting towards more efficient, automated solutions like real-time and digital PCR, enhancing speed and sensitivity, while portable devices broaden access to point-of-care applications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Polymerase Chain Reaction (PCR) market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Polymerase Chain Reaction (PCR) Market Segments Analysis

Global Polymerase Chain Reaction (PCR) Market is segmented by Type, Product, Indication, End User and region. Based on Type, the market is segmented into Standard PCR, Real-time PCR and Digital PCR. Based on Product, the market is segmented into Instruments and Reagents & Consumables. Based on Indication, the market is segmented into Infectious Diseases, Oncology, Genetic Disorders and Others. Based on End User, the market is segmented into Hospitals & Clinics, Pharmaceutical & Biotechnology Industries, Diagnostic Centers and Academic & Research Organizations. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Polymerase Chain Reaction (PCR) Market

The Polymerase Chain Reaction (PCR) market is significantly influenced by its widespread application in molecular diagnostics for the detection and monitoring of various diseases, including infectious diseases, cancers, and genetic disorders. The COVID-19 pandemic has notably heightened the need for accurate and rapid diagnostic tools, leading to an increased demand for PCR-based tests and diagnostics. This trend is expected to persist, further propelling the growth of the PCR market as healthcare providers and laboratories seek reliable solutions to facilitate timely diagnosis and effective patient management in the face of evolving health challenges.

Restraints in the Polymerase Chain Reaction (PCR) Market

The Polymerase Chain Reaction (PCR) market faces significant challenges due to the high costs associated with PCR units and consumables. This financial burden poses a substantial barrier for smaller laboratories, clinics, and research institutions that may struggle to afford the necessary equipment and materials. As a result, the limited accessibility of PCR technology in resource-constrained environments restricts its adoption and utilization, which could hinder overall market growth, particularly in developing regions where healthcare budgets are often tight. Addressing these economic constraints is crucial for expanding PCR applications and fostering advancements in diagnostic and research capabilities.

Market Trends of the Polymerase Chain Reaction (PCR) Market

The Polymerase Chain Reaction (PCR) market is witnessing a significant trend towards Point-of-Care (POC) PCR testing solutions, fueled by the growing need for rapid and on-site diagnostic capabilities, particularly highlighted during the COVID-19 pandemic. Healthcare providers are increasingly prioritizing quick results, which are crucial for managing infectious disease outbreaks and improving patient outcomes. The surge in demand for convenient testing options has led to a proliferation of POC PCR devices and kits, enhancing accessibility for healthcare facilities and patients alike. This shift not only streamlines the diagnostic process but also positions the POC PCR segment as a key driver of market growth.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Polymerase Chain Reaction (PCR) Market Size by Type & CAGR (2025-2032)

• Market Overview
• Standard PCR
• Real-time PCR
• Digital PCR

Global Polymerase Chain Reaction (PCR) Market Size by Product & CAGR (2025-2032)

• Market Overview
• Instruments
• Reagents & Consumables

Global Polymerase Chain Reaction (PCR) Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Infectious Diseases
• Oncology
• Genetic Disorders
• Others

Global Polymerase Chain Reaction (PCR) Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Industries
• Diagnostic Centers
• Academic & Research Organizations

Global Polymerase Chain Reaction (PCR) Market Size & CAGR (2025-2032)

• North America (Type, Product, Indication, End User)
  • US
  • Canada
• Europe (Type, Product, Indication, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Product, Indication, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Product, Indication, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Product, Indication, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuantuMDx Group Ltd (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eppendorf (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fluidigm Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microsynth AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JN Medsys (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations